Abdelrahman AE - Search Results

1

Clinicopathologic Impact of NANOG, ZEB1, and EpCAM Biomarkers on Prognosis of Serous Ovarian Carcinoma.

Ibrahim HM, Abdelrahman AE, Elsebai E, Gharieb SA, Fahmy MM, Ramadan MSH, Wasfy MA, Abdullatif A. Ibrahim HM, et al. Among authors: abdelrahman ae. Asian Pac J Cancer Prev. 2023 Sep 1;24(9):3247-3259. doi: 10.31557/APJCP.2023.24.9.3247. Asian Pac J Cancer Prev. 2023. PMID: 37774079 Free PMC article.

2

EZH2, Endothelin-1, and CD34 as Biomarkers of Aggressive Cervical Squamous Cell Carcinoma: An Immunohistochemical Study.

Fathy A, Abdelrahman AE. Fathy A, et al. Among authors: abdelrahman ae. Turk Patoloji Derg. 2018;34(2):150-57. doi: 10.5146/tjpath.2018.01425. Turk Patoloji Derg. 2018. PMID: 29630085 Free article.

3

Prognostic impact of Apaf-1, Cyclin D1, and AQP-5 in serous ovarian carcinoma treated with the first-line chemotherapy.

Abdelrahman AE, Fathy A, Elsebai EA, Nawar N, Etman WM. Abdelrahman AE, et al. Ann Diagn Pathol. 2018 Aug;35:27-37. doi: 10.1016/j.anndiagpath.2018.02.005. Epub 2018 Feb 21. Ann Diagn Pathol. 2018. PMID: 30072015

4

The clinicopathological significance of CD133 and Sox2 in astrocytic glioma.

Abdelrahman AE, Ibrahim HM, Elsebai EA, Ismail EI, Elmesallamy W. Abdelrahman AE, et al. Cancer Biomark. 2018;23(3):391-403. doi: 10.3233/CBM-181460. Cancer Biomark. 2018. PMID: 30248046

5

Fatty acid synthase, Her2/neu, and E2F1 as prognostic markers of progression in non-muscle invasive bladder cancer.

Abdelrahman AE, Rashed HE, Elkady E, Elsebai EA, El-Azony A, Matar I. Abdelrahman AE, et al. Ann Diagn Pathol. 2019 Apr;39:42-52. doi: 10.1016/j.anndiagpath.2019.01.002. Epub 2019 Jan 17. Ann Diagn Pathol. 2019. PMID: 30684846

6

C-MYC and BCL2: Correlation between Protein Over-Expression and Gene Translocation and Impact on Outcome in Diffuse Large B Cell Lymphoma.

Mohammed AA, Rashed HE, Abdelrahman AE, Obaya AA, Toam M, Abdel Nour HM, Abdelhamid MI, Elsayed FM. Mohammed AA, et al. Among authors: abdelrahman ae. Asian Pac J Cancer Prev. 2019 May 25;20(5):1463-1470. doi: 10.31557/APJCP.2019.20.5.1463. Asian Pac J Cancer Prev. 2019. PMID: 31127909 Free PMC article.

7

ERCC1, PARP-1, and AQP1 as predictive biomarkers in colon cancer patients receiving adjuvant chemotherapy.

Abdelrahman AE, Ibrahim DA, El-Azony A, Alnagar AA, Ibrahim A. Abdelrahman AE, et al. Cancer Biomark. 2020;27(2):251-264. doi: 10.3233/CBM-190994. Cancer Biomark. 2020. PMID: 31903985

8

Prognostic Impact of LGR5, Prox1, and Notch1 Biomarkers in Stage II to III Colon Cancer.

Abdelrahman AE, El-Azony A, Elsebai E, Ibrahim HM. Abdelrahman AE, et al. Appl Immunohistochem Mol Morphol. 2022 Feb 1;30(2):126-135. doi: 10.1097/PAI.0000000000000983. Appl Immunohistochem Mol Morphol. 2022. PMID: 34657081

9

Prognostic value of NOTCH1 and OCT4 in gastric carcinoma.

Ibrahim DA, Elsebai EA, Fayed A, Abdelrahman AE. Ibrahim DA, et al. Among authors: abdelrahman ae. Indian J Pathol Microbiol. 2022 Apr-Jun;65(2):328-335. doi: 10.4103/IJPM.IJPM_871_20. Indian J Pathol Microbiol. 2022. PMID: 35435367 Free article.

10

p53, Pirh2, and L1CAM as Promising Prognostic Biomarkers of Endometrial Carcinoma: An Immunohistochemical and Genetic Study.

Abdelrahman AE, Salem A, Al Attar AZ, Elsebai E, Samy W, Ibrahim MA, Ibrahim HM. Abdelrahman AE, et al. Appl Immunohistochem Mol Morphol. 2022 Nov-Dec 01;30(10):713-725. doi: 10.1097/PAI.0000000000001073. Epub 2022 Oct 17. Appl Immunohistochem Mol Morphol. 2022. PMID: 36251972

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

31 results

Search Page

Filters